期刊文献+

长疗程使用万古霉素肾毒性2例观察 被引量:4

Two cases observation of nephrotoxicity on long-term treatment with Vancomycin
下载PDF
导出
摘要 万古霉素是治疗G+球菌感染最重要的抗生素,但其肾毒性副作用也是危险的。本文观察2例急性髓性白血病患者,化疗后出现严重软组织感染,给予长疗程静脉使用万古霉素抗感染治疗,同时严密监控肾毒性发生情况。经过上述治疗,2例患者严重感染均得到有效控制直至痊愈,整个用药过程中2名患者均未出现明显的肾功能损伤情况。说明对于大多数患者而言,使用万古霉素进行抗感染治疗是有效的,而且肾毒性的发生率较低,不会因此而影响患者的主要治疗。 Vancomycin is the most important antibiotics towards G+ coccus,but the side effect of renal toxicity is danger too.This article reports two acute myeloid leukemia patients with severe soft tissue infection after chemotherapy treated with long-term intravenous infusion of vancomycin while closely monitoring the occurrence of renal toxicity.After the above treatment,two patients with severe infections had been effectively controlled until healed.Two patients showed no obvious renal function damage during the treatment.The outcome suggest that for the majority of patients,vancomycin is obvious and effective in anti-infection treatment.The incidence of nephrotoxicity is very low,so it should not affect the primary treatment of patients.
出处 《中国医药导报》 CAS 2012年第17期129-131,共3页 China Medical Herald
关键词 万古霉素 长疗程治疗 肾毒性 Vancomycin Long-term treatment Nephrotoxicity
  • 相关文献

参考文献7

二级参考文献41

共引文献58

同被引文献48

  • 1辛忠,张靓靓.盐酸去甲万古霉素临床应用研究[J].北方药学,2010,7(2):46-47. 被引量:1
  • 2申阿东,杨永弘,黄醒华,张桂荣.B组链球菌临床分离株表型和分子流行病学方法的研究[J].医学研究通讯,2004,33(10):25-25. 被引量:8
  • 3朱敏,范建霞,程利南.围产期B族链球菌感染的研究进展[J].中华妇产科杂志,2005,40(2):137-141. 被引量:110
  • 4桑敏.盐酸去甲万古霉素在临床应用中的1例典型不良反应[J].中外健康文摘,2009,6(29):284.
  • 5Ronald SG, Stephanie S,Anne S. Perinatal infections due to group B streptococci [J]. Obster Gyneeol,2004,104 (5):1062-1076.
  • 6Curry L,Mahmood TA,Hughes R. The ethics of screening for group B streptococcus in pregnancy [J]. Obstet Gynecol, 2014,24 (2) : 62-64.
  • 7Cockerill FR. Performance Standards for Antimicrobial Susceptibility Testing:Twenty -Second Informational Supplement [M]. Clinical and Laboratory Standards Institute, 2014.
  • 8Wikler MA. Performance standards for antimicrobial susceptibility testing:sixteenth informational supplem ent [M].Clinical and Laboratory Standards Institute, 2006.
  • 9Varain JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010 [J]. MMWR Recomm Rep, 2010, 59 (10) : 1 - 36.
  • 10Cagno CK,Pettit JM,Weiss BD. Prevention of perinatal group B streptococcal disease:update CDC guideline [J]. Am Fam Physician, 2012,86( 1 ) : 59-65.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部